Supriya Lifescience Limited has announced that it will host an earnings call on November 13, 2025, at 11:00 A.M. IST to discuss its operational and financial performance for the second quarter and half year ended September 30, 2025. This call is being arranged in compliance with the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, ensuring that stakeholders are kept informed of the company's financial health. The earnings call will allow investors and analysts to gain insights into the company’s recent performance and future outlook.

The invitation for the earnings call includes a pre-registration link and dial-in details, which will facilitate participation from interested parties. In addition, an investor presentation will be shared separately with the stock exchanges, providing further context and data points for the discussion. Supriya Lifescience has established itself as a recognized export house, and this call aims to reinforce transparency and communication with its investors and stakeholders.

Key representatives from management will be present on the call, including Dr. Satish Wagh, Executive Chairman, and Dr. Saloni Wagh, Managing Director, along with Mr. Krishna Raghunathan, Chief Financial Officer. Participants will have access to multiple dial-in numbers from various regions, including the USA, UK, and Hong Kong, ensuring a broad reach. As Supriya Lifescience continues to innovate and expand its operations, this earnings call is poised to provide clarity and insight into its financial trajectory as it navigates the competitive landscape of the lifesciences sector.